Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
- PMID: 18834626
- PMCID: PMC2803340
- DOI: 10.1016/S0140-6736(08)61343-4
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
Abstract
Background: Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout.
Methods: Genome-wide association studies were done for serum uric acid in 7699 participants in the Framingham cohort and in 4148 participants in the Rotterdam cohort. Genome-wide significant single nucleotide polymorphisms (SNPs) were replicated in white (n=11 024) and black (n=3843) individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). The SNPs that reached genome-wide significant association with uric acid in either the Framingham cohort (p<5.0 x 10(-8)) or the Rotterdam cohort (p<1.0 x 10(-7)) were evaluated with gout. The results obtained in white participants were combined using meta-analysis.
Findings: Three loci in the Framingham cohort and two in the Rotterdam cohort showed genome-wide association with uric acid. Top SNPs in each locus were: missense rs16890979 in SLC2A9 (p=7.0 x 10(-168) and 2.9 x 10(-18) for white and black participants, respectively); missense rs2231142 in ABCG2 (p=2.5 x 10(-60) and 9.8 x 10(-4)), and rs1165205 in SLC17A3 (p=3.3 x 10(-26) and 0.33). All SNPs were direction-consistent with gout in white participants: rs16890979 (OR 0.59 per T allele, 95% CI 0.52-0.68, p=7.0 x 10(-14)), rs2231142 (1.74, 1.51-1.99, p=3.3 x 10(-15)), and rs1165205 (0.85, 0.77-0.94, p=0.002). In black participants of the ARIC study, rs2231142 was direction-consistent with gout (1.71, 1.06-2.77, p=0.028). An additive genetic risk score of high-risk alleles at the three loci showed graded associations with uric acid (272-351 mumol/L in the Framingham cohort, 269-386 mumol/L in the Rotterdam cohort, and 303-426 mumol/L in white participants of the ARIC study) and gout (frequency 2-13% in the Framingham cohort, 2-8% in the Rotterdam cohort, and 1-18% in white participants in the ARIC study).
Interpretation: We identified three genetic loci associated with uric acid concentration and gout. A score based on genes with a putative role in renal urate handling showed a substantial risk for gout.
Figures
Comment in
-
Understanding deficient elimination of uric acid.Lancet. 2008 Dec 6;372(9654):1929-30. doi: 10.1016/S0140-6736(08)61344-6. Epub 2008 Oct 1. Lancet. 2008. PMID: 18834627 No abstract available.
-
A sugar transporter regulates serum urate levels: implications for prevention and management of hyperuricemia in gout.Curr Rheumatol Rep. 2009 Apr;11(2):83-6. doi: 10.1007/s11926-009-0012-6. Curr Rheumatol Rep. 2009. PMID: 19296879 No abstract available.
Similar articles
-
GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.Int J Rheum Dis. 2018 Jun;21(6):1270-1276. doi: 10.1111/1756-185X.13323. Int J Rheum Dis. 2018. PMID: 29879316
-
The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.Rheumatology (Oxford). 2010 Aug;49(8):1461-5. doi: 10.1093/rheumatology/keq096. Epub 2010 Apr 25. Rheumatology (Oxford). 2010. PMID: 20421215
-
The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.BMC Med Genet. 2020 Oct 21;21(1):210. doi: 10.1186/s12881-020-01147-2. BMC Med Genet. 2020. PMID: 33087043 Free PMC article.
-
Genetics of gout.Curr Opin Rheumatol. 2010 Mar;22(2):144-51. doi: 10.1097/BOR.0b013e32833645e8. Curr Opin Rheumatol. 2010. PMID: 20110790 Review.
-
An update on the genetic architecture of hyperuricemia and gout.Arthritis Res Ther. 2015 Apr 10;17(1):98. doi: 10.1186/s13075-015-0609-2. Arthritis Res Ther. 2015. PMID: 25889045 Free PMC article. Review.
Cited by
-
SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids.Front Cell Dev Biol. 2024 Jan 10;11:1268226. doi: 10.3389/fcell.2023.1268226. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38269090 Free PMC article.
-
Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.Dis Markers. 2024 Jan 6;2024:5930566. doi: 10.1155/2024/5930566. eCollection 2024. Dis Markers. 2024. PMID: 38222853 Free PMC article.
-
Linkage analysis using whole exome sequencing data implicates SLC17A1, SLC17A3, TATDN2 and TMEM131L in type 1 diabetes in Kuwaiti families.Sci Rep. 2023 Sep 11;13(1):14978. doi: 10.1038/s41598-023-42255-2. Sci Rep. 2023. PMID: 37696853 Free PMC article.
-
How Cryo-EM Has Expanded Our Understanding of Membrane Transporters.Drug Metab Dispos. 2023 Aug;51(8):904-922. doi: 10.1124/dmd.122.001004. Epub 2023 Jul 12. Drug Metab Dispos. 2023. PMID: 37438132 Free PMC article. Review.
-
GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study.J Hum Genet. 2023 Oct;68(10):699-704. doi: 10.1038/s10038-023-01168-8. Epub 2023 Jun 13. J Hum Genet. 2023. PMID: 37308567
References
-
- Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005 Oct 4;143(7):499–516. - PubMed
-
- Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008 Mar;35(3):498–501. - PubMed
-
- Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm. 2008 Mar;14(2):164–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01HC55020/HL/NHLBI NIH HHS/United States
- N02-HL-6-4278/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- N01 HC055022/HC/NHLBI NIH HHS/United States
- N01HC55018/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01-HC-55022/HC/NHLBI NIH HHS/United States
- UL1 RR 025005/RR/NCRR NIH HHS/United States
- N01-HC-55016/HC/NHLBI NIH HHS/United States
- N01 HC055018/HC/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- N02 HL64278/HL/NHLBI NIH HHS/United States
- R01DK076770-01/DK/NIDDK NIH HHS/United States
- N01HC55022/HL/NHLBI NIH HHS/United States
- N01-HC-55021/HC/NHLBI NIH HHS/United States
- N01HC55015/HL/NHLBI NIH HHS/United States
- N01 HC055019/HC/NHLBI NIH HHS/United States
- N01-HC-55019/HC/NHLBI NIH HHS/United States
- R01 DK076770-01/DK/NIDDK NIH HHS/United States
- N01-HC-55015/HC/NHLBI NIH HHS/United States
- N01-HC-55020/HC/NHLBI NIH HHS/United States
- N01HC55016/HL/NHLBI NIH HHS/United States
- R01 DK076770/DK/NIDDK NIH HHS/United States
- N01 HC055015/HC/NHLBI NIH HHS/United States
- N01 HC055021/HC/NHLBI NIH HHS/United States
- UL1 RR025005-01/RR/NCRR NIH HHS/United States
- N01HC55019/HL/NHLBI NIH HHS/United States
- N01HC25195/HL/NHLBI NIH HHS/United States
- N01 HC055020/HC/NHLBI NIH HHS/United States
- N01-HC-55018/HC/NHLBI NIH HHS/United States
- N01HC55021/HL/NHLBI NIH HHS/United States
- N01 HC055016/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
